Malignant Paraganglioma: Clinical Trials

1 trial for Malignant Paraganglioma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1

Follow Malignant Paraganglioma: new trials by email Literature Review of Malignant Paraganglioma trials Research Report on Malignant Paraganglioma

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine Cancer
Computed Tomography, Dual X-ray Absorptiometry, Physical Examination - Differentiated Thyroid Gland Carcinoma, Malignant Adrenal Gland Pheochromocytoma
Not applicableCompletedM.D. Anderson Cancer Center232015-11-162024-03-05

Narrower conditions

Carcinoma, Medullary (1)  ·  Paraganglioma, Extra-Adrenal (1)

Broader conditions

Adenocarcinoma (1)  ·  Carcinoma (1)  ·  Carcinoma, Neuroendocrine (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Ductal, Lobular, and Medullary (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Neuroectodermal Tumors (1)  ·  Neuroendocrine Tumors (1)  ·  Paraganglioma (1)

Interventions

Absorptiometry, Photon (1)  ·  Restraint, Physical (1)  ·  cabozantinib (1)  ·  lenvatinib (1)

Sponsors

M.D. Anderson Cancer Center (1)

Countries

United States (1)

Top investigators

Naifa L Busaidy (1)